Skip to main content
. 2021 Feb 16;8(2):241–251. doi: 10.1007/s40801-021-00233-y

Table 3.

Adverse events by age group

Children (n = 230) Adolescents (n = 138) Adults (n = 433)
Patients, n (%) Events, n Patients, n (%) Events, n Patients, n (%) Events, n
Total 13 (5.7) 15 5 (3.6)a 6 36 (8.3) 47
Gastrointestinal disorders 10 (4.3) 10 4 (2.9) 5 30 (6.9) 36
 Oral pruritus 4 (1.7) 4 3 (2.2) 3 15 (3.5) 15
 Pruritus of tongue 0 0 1 (0.7) 1 7 (1.6) 7
 Abdominal pain 4 (1.7) 4 0 0 1 (0.2) 1
 Glossodynia 2 (0.9) 2 1 (0.7) 1 1 (0.2) 1
 Upper abdominal pain 0 0 0 0 3 (0.7) 3
 Swollen tongue 0 0 0 0 2 (0.5) 2
 Pruritus of the lips 0 0 0 0 2 (0.5) 2
 Gastrointestinal disorder 0 0 0 0 2 (0.5) 2
 Diarrhoea 0 0 0 0 1 (0.2) 1
 Gastroesophageal reflux disease 0 0 0 0 1 (0.2) 1
 Gastric reflux 0 0 0 0 1 (0.2) 1
Skin and skin structure disorders 2 (0.9) 2 1 (0.7) 1 5 (1.2) 5
 Angioedema 0 0 0 0 3 (0.7) 3
 Pruritus 1 (0.4) 1 1 (0.7) 1 1 (0.2) 1
 Urticaria 1 (0.4) 1 0 0 1 (0.2) 1
Nervous system disorders 1 (0.4) 1 0 0 1 (0.2) 1
 Headache 1 (0.4) 1 0 0 1 (0.2) 1
Respiratory, thoracic and mediastinal disorders 1 (0.4) 1 0 0 1 (0.2) 1
 Dyspnoea 0 0 0 0 1 (0.2) 1
 Irritated throat 1 (0.4) 1 0 0 0 0
Infections and infestations 1 (0.4) 1 0 0 0 0
 Rhinitis 1 (0.4) 1 0 0 0 0
Ear and labyrinth disorders 0 0 0 0 1 (0.2) 1
 Pruritus in the ear 0 0 0 0 1 (0.2) 1
General disorders and changes in administration site 0 0 0 0 1 (0.2) 1
 Poorly defined disorder 0 0 0 0 1 (0.2) 1
Ocular disorders 0 0 0 0 1 (0.2) 1
 Pruritus in the eye 0 0 0 0 1 (0.2) 1
Psychiatric disorders 0 0 0 0 1 (0.2) 1
 Anxiety 0 0 0 0 1 (0.2) 1

The list of adverse events is presented using the system organ class and preferred terms of the Medical Dictionary for Regulatory Activities

aNo differences were identified between age groups (p > 0.05), except for the total number of cases in adolescents, significantly lower than in the adult group (p = 0.0012)